Stocks  /  NASDAQ  /  Scribe Therapeutics Inc.

Scribe Therapeutics Inc.

Industry:   Health Care – Biotechnology: Biological Products (No Diagnostic Substances)

Stock Symbol:   SCTX – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Scribe Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for drug testing.

“The Symposia Spotlight presentation showcases Scribe’s CRISPR by DesignTM approach to engineering potent ELXRs with newly uncovered repressor domains and their validation in animal models, including non-human primates. Notably, a single dose of ELXR using a newly identified repressor domain achieved ~90% repression of PCSK9—a key driver of dyslipidemia—lasting at least 150 days in non-human primates.” Read the following article

Company Description

Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company was incorporated in 2017 and is headquartered in Alameda, California.

Company Website: https://www.scribetx.com

Contact:  ir@scribetx.com
Scroll to Top